PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
93 hedge funds and large institutions have $92.2M invested in Paratek Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.84%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
14
Increased
38
Reduced
22
Closed
12
Calls
$350K
Puts
$414K
Net Calls
-$64K
Net Calls Change
-$309K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$6.17M |
| 2 |
AC
2
Armistice Capital
New York
|
$9.14M |
| 3 |
GIM
3
Granahan Investment Management
Waltham,
Massachusetts
|
$2.87M |
| 4 |
PM
4
Prosight Management
Dallas,
Texas
|
$1.81M |
| 5 |
5
D.E. Shaw & Co
New York
|
$1.05M |
